Side-by-side comparison
NVS vs MRK — Side-by-side comparison
MRK screens cheaper on EV/FCF, MRK has the higher ROIC, MRK has grown revenue faster over five years, and Neither has the cleaner balance sheet by net debt / EBITDA.
NVS
Novartis AG
Price
$152.01
Market cap
$223.3B
Day %
N/A
MRK
Merck & Co.
Price
$122.41
Market cap
$208.5B
Day %
N/A
Peer Comparison
Target stock against 1 market-cap comparable peer.
Heat map: red worst to green best
NVS implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
N/A
MRK implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
15.7x
FCF yield
5.9%
5Y rev CAGR
9.4%
5Y indexed stock chart
Static Recharts view indexed to 100 from available annual per-share data.
Quality Scorecard
Build-time composite score for NVS.
Grade F
0
/ 100
Quality Radar0 – 20 per axis
Quality Scorecard
Build-time composite score for MRK.
Grade C
57
/ 100
Quality Radar0 – 20 per axis